Literature DB >> 25399937

Small vessel vasculitis of the skin.

Robert G Micheletti1, Victoria P Werth2.   

Abstract

Small vessel vasculitis in the skin manifests with palpable purpura on the lower extremities. This clinical presentation prompts a complete physical examination, history, and review of systems, as well as biopsies for routine processing and direct immunofluorescence to confirm the diagnosis. The presence of vasculitis in other organs, associated underlying conditions, and the severity of cutaneous manifestations dictate management. The majority of cases are self-limited, and overall the prognosis is favorable. Still, a subset of patients can have serious complications and chronic or recurrent disease.

Entities:  

Keywords:  Cutaneous vasculitis; Henoch-Schonlein purpura; Hypersensitivity vasculitis; IgA vasculitis; Leukocytoclastic vasculitis; Small vessel vasculitis of the skin

Mesh:

Substances:

Year:  2015        PMID: 25399937     DOI: 10.1016/j.rdc.2014.09.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  15 in total

1.  Nafcillin implicated in a case of cutaneous and gastrointestinal leukocytoclastic vasculitis.

Authors:  Changqing Xie; Suchita S Pancholi; Niti Armistead
Journal:  J Clin Diagn Res       Date:  2015-04-01

2.  Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.

Authors:  Xu Teng; Cuiyun Gao; Mei Sun; Jie Wu
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

Review 3.  Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood.

Authors:  Sebastiano A G Lava; Gregorio P Milani; Emilio F Fossali; Giacomo D Simonetti; Carlo Agostoni; Mario G Bianchetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

4.  Adult-Onset Henoch-Schonlein Purpura Duodenitis.

Authors:  Emmanuel Ofori; Daryl Ramai; Mel A Ona; Charilaos Papafragkakis; Madhavi Reddy
Journal:  J Clin Med Res       Date:  2017-10-02

5.  Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers.

Authors:  Thilo Gambichler; Magdalena A Kulik; Marina Skrygan; Isabelle Rooms; Stefan Höxtermann
Journal:  Postepy Dermatol Alergol       Date:  2017-08-01       Impact factor: 1.837

6.  Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban.

Authors:  Nuri Barış Hasbal; Taner Baştürk; Yener Koç; Tuncay Sahutoğlu; Feyza Bayrakdar Çağlayan; Abdülkadir Ünsal
Journal:  Turk J Haematol       Date:  2016-10-31       Impact factor: 1.831

7.  Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Authors:  Mohamed Mohamoud; Casie Horgan; Efe Eworuke; Elizabeth Dee; Justin Bohn; Oren Shapira; Monica A Munoz; Danijela Stojanovic; Veronica Sansing-Foster; Adebola Ajao; Lois La Grenade
Journal:  Pharmacotherapy       Date:  2020-11-08       Impact factor: 6.251

8.  Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases.

Authors:  Lampros Fotis; Paul V Tuttle; Kevin W Baszis; Peri H Pepmueller; Terry L Moore; Andrew J White
Journal:  Pediatr Rheumatol Online J       Date:  2016-06-23       Impact factor: 3.054

Review 9.  Necroptosis and neutrophil-associated disorders.

Authors:  Xiaoliang Wang; Shida Yousefi; Hans-Uwe Simon
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

10.  Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.

Authors:  Sira Nanthapisal; Despina Eleftheriou; Kimberly Gilmour; Valentina Leone; Radhika Ramnath; Ebun Omoyinmi; Ying Hong; Nigel Klein; Paul A Brogan
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.